Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-005611

Options or other derivatives

  • Chief Financial Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sassi Nir Chief Financial Officer 2022-02-25 Grant or award · Stock Option (right to buy) +60,000 60,000 D
Loading xslF345X03/ownership.xml…